I listened to most of the webcast and read all the slides, nothing new. It's all coming down to Dec 2012 the 4 Phase 2 results if good to great Geron will be $5 to $10 a share, if bad to fair, 5 to 10 cents a share. The market moved Geron down to $1.53 on 624,098 shares. The three month avg. is 707,994 shares.
ACTC was up a little at 0.084, on great volume 18.3 million shares. The avg. three month is 5 million shares.
With ACTC's problem which are many, it all comes down to good results on the Phase 1/2 trials.
AAPL down again to $598.90 on 15.3 shares. The three month avg. is 18.4 million shares. If they miss earnings look out.
Good luck in this rigged casino,
No comments:
Post a Comment